therapeutic 1,646 words KG: Huntington
Contents

huntington-disease-treatment

💊 Therapeutic Info
NameHuntington
Key Genes/ProteinsAADC, ACETYL-COA, ACTB, ACTG1, Actin, ADAM10
Related DiseasesAging, Als
Related PathwaysAkt

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (103)

TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Lysosomal Enzyme Trafficking Correction
Score: 0.71
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.70
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.70
Axonal RNA Transport Reconstitution
Score: 0.70
Mitochondrial Transfer Pathway Enhancement
Score: 0.70
Complement C1q Mimetic Decoy Therapy
Score: 0.69
Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th
Score: 0.69
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69
Ocular Immune Privilege Extension
Score: 0.69
Cross-Seeding Prevention Strategy
Score: 0.69
Lysosomal Positioning Dynamics Modulation
Score: 0.69
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.69
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.68
Context-Dependent CRISPR Activation in Specific Neuronal Sub
Score: 0.68
← Prevpg 3/6Next →

Related Analyses (30)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived

Related Experiments (9)

Microglial Contributions to Huntington's Disease Pathogenesi
validation · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
Epigenetic Dysregulation in Huntington's Disease — Therapeut
validation · completed · Score: 0.40
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · completed · Score: 0.90
AMPK knockdown validation experiment
exploratory · proposed · Score: 0.88

See Also (5)

ACTB Gene
gene · KG edge: therapeutic_target
ACTG1 Gene
gene · KG edge: therapeutic_target
ADAM10 — A Disintegrin And Metalloproteinase Domain 10
gene · KG edge: inhibits
Packard Center for ALS Research
institution · KG edge: activates
Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: activates

Knowledge Graph (12 edges)

STIP1 associated_with Huntington
LGALS3 associated_with Huntington
HSPA8 associated_with Huntington
MCOLN1 associated_with Huntington
SQSTM1 associated_with Huntington
BCL2 associated_with Huntington
CTSB associated_with Huntington
TPP1 associated_with Huntington
GLA associated_with Huntington
CALCINEURIN activates Huntington

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.